abstract |
The present invention relates to 18-methyl-6,7-methylene-17-pregn-4 -en-21,17β-carbolactone of the general formula I (see Formula) wherein the 6,7-methylene group may be in the position a or ß, pharmaceutical preparations containing at least one isomer of the formula I, as well as its use in the treatment of endometriosis. |